What’s new

  • TOP
  • What’s new
  • New! HRP-conjugated Anti-DXd/Exatecan Antibody – Now Available

New! HRP-conjugated Anti-DXd/Exatecan Antibody – Now Available

Products


update: 2025/10/1






















Boost Your ADC Research – New HRP-labeled Anti-DXd Antibody



Perseus Proteomics Inc.


Introduction: Antibody-drug conjugates (ADCs) are transforming oncology research by enabling highly targeted therapies. Recent studies focus on improving efficacy and safety in both hematologic and solid tumors, while expanding applications in personalized medicine and combination therapies.



As part of our Anti-ADC (Antibody-Drug Conjugate) Antibody Series, Perseus Proteomics Inc. have previously launched the Anti-DM1 Antibody and Anti-MMAE Antibody. Perseus Proteomics Inc. is now pleased to announce the release of the third product in this series: the HRP-conjugated Anti-DXd/Exatecan Antibody.


 


In addition, our new Anti-GPR87 Antibody—developed based on validation studies conducted in collaboration with a university and published in an international scientific journal*—is now available as a research-use-only reagent.


 


*Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised antiGPR87 mAb and therapeutic efficacy on a lung cancer mouse model, EBioMedicine

































































　product name
　HRP conjugated Anti DXd/Exatecan human monoclonal antibody

　cat#
　PP-AB12703-0R

　unit size
　0.5 mg/mL, 50 uL
　Application
　ELISA

　remark
　

　product name
　Anti human GPR87 mouse monoclonal antibody (ProteinA purified)_C0804

　cat#
　PP-C0804-0C

　unit size
　1mg/mL, 100 uL
　Application
　IHC

　remark
　clone# C804

　product name
　Anti human GPR87 mouse monoclonal antibody (ProteinA purified)_C0812

　cat#
　PP-C0812-0C

　unit size
　1mg/mL, 100 uL
　Application
　IHC

　remark
　clone# C812

　　


contact us



General: export@denispharma.jp



Technical Support: technicalsupport@denispharma.jp


Keyword: pharmacokinetics (PK), bystander effect, payload release, therapeutic window, clinical translation, biomarker development, companion diagnostics, tissue specificity, patient stratification, target validation


Please contact about our products and sevice.
Contact
Research Reagents Department / Diagnostics and Reagents Section
TEL:03-5510-2652